Muscle and Bone Health in Postmenopausal Women: Role of Protein and Vitamin D Supplementation Combined with Exercise Training.
Deborah AgostiniSabrina Donati ZeppaFrancesco LucertiniGiosuè AnnibaliniMarco GervasiCarlo Ferri MariniGiovanni PiccoliVilberto StocchiElena BarbieriPiero SestiliPublished in: Nutrients (2018)
Menopause is an age-dependent physiological condition associated with a natural decline in oestrogen levels, which causes a progressive decrease of muscle mass and strength and bone density. Sarcopenia and osteoporosis often coexist in elderly people, with a prevalence of the latter in elderly women. The profound interaction between muscle and bone induces a negative resonance between the two tissues affected by these disorders worsening the quality of life in the postmenopausal period. It has been estimated that at least 1 in 3 women over age 50 will experience osteoporotic fractures, often requiring hospitalisation and long-term care, causing a large financial burden to health insurance systems. Hormonal replacement therapy is effective in osteoporosis prevention, but concerns have been raised with regard to its safety. On the whole, the increase in life expectancy for postmenopausal women along with the need to improve their quality of life makes it necessary to develop specific and safe therapeutic strategies, alternative to hormonal replacement therapy, targeting both sarcopenia and osteoporosis progression. This review will examine the rationale and the effects of dietary protein, vitamin D and calcium supplementation combined with a specifically-designed exercise training prescription as a strategy to counteract these postmenopausal-associated disorders.
Keyphrases
- bone mineral density
- postmenopausal women
- replacement therapy
- skeletal muscle
- polycystic ovary syndrome
- health insurance
- smoking cessation
- insulin resistance
- long term care
- community dwelling
- affordable care act
- healthcare
- middle aged
- public health
- gene expression
- multiple sclerosis
- pregnancy outcomes
- clinical trial
- mental health
- protein protein
- body composition
- binding protein
- breast cancer risk
- metabolic syndrome
- adipose tissue
- drug delivery
- young adults
- intellectual disability
- quantum dots
- health promotion